These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Song C; Liao S Endocrinology; 2000 Nov; 141(11):4180-4. PubMed ID: 11089551 [TBL] [Abstract][Full Text] [Related]
10. The LXRs: a new class of oxysterol receptors. Peet DJ; Janowski BA; Mangelsdorf DJ Curr Opin Genet Dev; 1998 Oct; 8(5):571-5. PubMed ID: 9794827 [TBL] [Abstract][Full Text] [Related]
11. PPARs: nuclear receptors for fatty acids, eicosanoids, and xenobiotics. Devchand PR; Ijpenberg A; Devesvergne B; Wahli W Adv Exp Med Biol; 1999; 469():231-6. PubMed ID: 10667335 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076 [TBL] [Abstract][Full Text] [Related]
13. Lipid research. Possible new way to lower cholesterol. Ferber D Science; 2000 Sep; 289(5484):1446-7. PubMed ID: 10991725 [TBL] [Abstract][Full Text] [Related]
15. Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Trottier J; Milkiewicz P; Kaeding J; Verreault M; Barbier O Mol Pharm; 2006; 3(3):212-22. PubMed ID: 16749854 [TBL] [Abstract][Full Text] [Related]
16. Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Lavrentiadou SN; Hadzopoulou-Cladaras M; Kardassis D; Zannis VI Biochemistry; 1999 Jan; 38(3):964-75. PubMed ID: 9893992 [TBL] [Abstract][Full Text] [Related]
17. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063 [TBL] [Abstract][Full Text] [Related]
18. FXR, a therapeutic target for bile acid and lipid disorders. Westin S; Heyman RA; Martin R Mini Rev Med Chem; 2005 Aug; 5(8):719-27. PubMed ID: 16101408 [TBL] [Abstract][Full Text] [Related]
19. A regulatory role for RIP140 in nuclear receptor activation. Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662 [TBL] [Abstract][Full Text] [Related]
20. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]